寻找2026中国医药大健康产业风起之源

Core Viewpoint - The 2025 China Pharmaceutical Health Industry Summit Forum aims to address the significant restructuring of the industry, focusing on innovation, strategic capital integration, and responding to new consumer demands in the healthcare sector [9][10][11]. Group 1: Forum Agenda - The forum will take place on December 10, 2025, featuring a series of keynote speeches and roundtable discussions from industry leaders and experts [4][5][14]. - Keynote speakers include prominent figures such as Feng Guosheng from the Chinese Medical Association and Yao Jianping from Anhui Anke Bioengineering [4][5]. - The agenda includes discussions on high-quality development, humanistic care in critical conditions, and growth opportunities under industry reconstruction [5][6]. Group 2: Industry Challenges and Opportunities - The era of relying on generic drug advantages and channel strategies is over, leading to a complete restructuring of industry value [9]. - The core competitiveness of the pharmaceutical health industry is being redefined around three key questions: global product value, strategic capital integration, and responsiveness to demand shifts [10]. - The forum is positioned as a critical alignment event for industry executives, investors, and analysts to identify clear and executable growth paths for the next 3-5 years [11][13]. Group 3: Value Propositions of the Forum - The forum emphasizes the transition from "borrowing boats to go to sea" to "building ships for long voyages," addressing the real challenges of global clinical and commercial innovation [12]. - It aims to provide insights from a buy-side perspective on how to select and invest in future industry leaders amid a new valuation norm [13]. - The forum seeks to uncover new growth areas within the changing landscape of healthcare insurance and consumer markets, focusing on a model that integrates products and services [13].